Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Analysis

Pre-exposure prophylaxis and primary care

Des Crowley, Walter Cullen and Patrick O’Donnell
British Journal of General Practice 2020; 70 (697): 409-410. DOI: https://doi.org/10.3399/bjgp20X712097
Des Crowley
Irish College of General Practitioners; Senior Lecturer, School of Medicine, University College Dublin, Dublin, Republic of Ireland.
Roles: Assistant Director of the Addiction Management Programme
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Cullen
School of Medicine, University College Dublin, Dublin, Republic of Ireland.
Roles: Professor of Urban General Practice
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick O’Donnell
Graduate Entry Medical School, University of Limerick, Limerick, Republic of Ireland.
Roles: Clinical Fellow in Social Inclusion and PhD Candidate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

INTRODUCTION

Despite the increasing evidence of the effectiveness of pre-exposure prophylaxis (PrEP) as a HIV prevention strategy, its usefulness is rarely reported in the general practice literature.1

HIV infection remains a major public health concern worldwide and it is men who have sex with men (MSM) that carry a disproportionate amount of the disease burden.2 Despite evidence that the rate of new HIV infections in the UK is falling, the rate among young MSM is a cause for concern.2 The Republic of Ireland (ROI) has not seen a similar decline, with 523 new HIV cases diagnosed in Ireland in 2018.3 Similar to other European countries, the main risk for HIV transmission in Ireland is sex among men.2,3

HEALTH DISPARITIES AND MINORITY STRESS

With the recent introduction of legislation allowing same sex marriage in both the UK and Ireland, there is increasing acceptance of LGBT people; however, many LGBT people continue to experience stigma and discrimination.4

It is recognised that LGBT people experience inequalities across a range of health issues when compared to heterosexuals; including higher levels of anxiety, depression, self-harm, suicide, and drug dependence.4 Minority stress may explain some of these identified disparities,5 and this theory has also been proposed as an explanation for the high levels of risk-taking behaviour seen in MSM populations.5 Marginalisation and stigma are certainly recognised as factors that contribute to people engaging in risky behaviour.5

A COMPREHENSIVE APPROACH TO HIV PREVENTION

A wide range of HIV prevention initiatives aimed at MSM have been taking place for many years, including: HIV testing, STI testing and treatment, condom provision, education around sexual behaviour, alcohol and substance misuse, PrEP, and treatment as prevention.6 These programmes have been introduced at a challenging time, with increasing levels of sexualised drug use among MSM facilitated by the internet and smartphone applications.7,8 Ongoing HIV-related stigma also impacts negatively on the success of these prevention programmes.6

Alternative HIV prevention approaches are needed, and PrEP is a promising option. PrEP involves people who are HIV negative taking oral antiretrovirals (most commonly a combination of tenofovir and emtricitabine) to prevent infection. PrEP has been demonstrated to be highly efficacious among MSM.9 PrEP should be provided along with holistic assessment, frequent testing for HIV and other STIs, advice on safer sex practices, and medication adherence support and counselling for individuals at substantial risk of infection.

PRE-EXPOSURE PROPHYLAXIS IN IRELAND AND THE UK

Both in the ROI and UK, Health Technology Assessments (HTAs) have shown that the provision of PrEP is cost effective and has the potential to prevent a significant number of new HIV infections.10,11

PrEP is now available in healthcare settings across the ROI and the UK. In the UK, PrEP is provided on a trial or pilot basis and through sexual health clinics. Since November 2019, the ROI has begun the roll out of a national PrEP programme. In addition, it is recognised that there are significant numbers of MSM self-sourcing PrEP in both jurisdictions.1

The Irish programme does not specifically exclude general practices from providing PrEP, but to date, it is only being provided at specialist sexual health clinics. The UK PrEP programmes specifically exclude routine primary care.

The Irish HTA reported concerns regarding ‘existing capacity constraints, staffing and infrastructural issues of public STI services’, and advised that, ‘significant investment in the broader service may be necessary to support the provision of a safe, sustainable and equitable PrEP programme’.10

‘PrEP GAP’

This ‘PrEP gap’ is the level of unmet need that exists for PrEP. It is recommended that PrEP be integrated into existing HIV prevention programmes targeting those most at risk of HIV infection.12 The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a global target that 3 million people would have access to PrEP by 2020. Despite this, over 500 000 MSM in the EU who would be likely to use PrEP do not yet have access to it.12 A recent study among Irish MSM reports a significant PrEP gap.13 The longer the delay in access to PrEP for these men, the higher the likelihood that more HIV infections will occur. PrEP’s potential to eliminate HIV is currently unrealised by national healthcare systems. In order to accelerate progress towards ending the AIDS epidemic by 2030, a much wider implementation of PrEP services will be required, including its expansion into routine primary care.

SEXUAL ORIENTATION DISCLOSURE

Many LGBT people do not disclose their sexual orientation to healthcare professionals.14 This failure is associated with the fear of a negative reaction and can have an impact on LGBT people accessing appropriate and timely healthcare. GPs are well placed to facilitate disclosure and reduce associated stigma.1,14

GP surgeries should be safe places at which patients can discuss sexual orientation, with GPs’ communication skills (both verbal and non-verbal) facilitating this by being accepting and inclusive.14 GPs are well placed to manage the other identified healthcare needs of LGBT patients, including mental health and drug dependency, which are rarely managed in STI services.1 The provision of PrEP in primary care has the added benefit of improving general healthcare uptake by MSM, which in the long term could reduce the identified health inequalities experienced by this population.15

Provision of STI screening services for all patients at primary care level is underdeveloped.10 Primary care in Ireland is neither resourced nor encouraged to expand STI screening services. Sexual health care for MSM is often seen as a specialist area, and GPs are recommended to refer to specialist sexual health clinics. Many GPs are well equipped to manage the complexity of STI management in MSM.

Expanding sexual services into primary care settings has the potential to reduce stigma and improve access to STI screening and PrEP, and to engage many more MSM in HIV prevention.15 Up to now, public health efforts to engage high-risk MSM in HIV prevention has been a struggle and has had limited success.6 It is now timely to shift the focus and support routine primary care as a key location to engage this at-risk group.

CONCLUSION AND RECOMMENDATIONS

Policy makers and healthcare funders in the UK and Ireland are failing to recognise the potential of primary care services, including general practice, to deliver this effective HIV prevention strategy. Sláintecare, Ireland’s 10-year health policy, has the stated aim of ‘deliver a universal health service that offers the right care, in the right place, at the right time, with a priority focus on developing primary and community services within a national policy context’,16 and the provision of PrEP in primary care settings would really support that.

In the UK and Ireland, primary care services are ideal locations to implement PrEP services delivered within a broader HIV prevention framework, and so they should be supported to maximise this potential. At the same time, medical schools and GP training schemes must ensure that there is work done on education around LGBT health care. If this is done, then our national health services, and especially general practice, will begin to address the issues of minority stress and stigma, which impacts so negatively on LGBT health and HIV prevention strategies among MSM.

Notes

Provenance

Freely submitted; externally peer reviewed.

  • © British Journal of General Practice 2020

REFERENCES

  1. 1.↵
    1. Wereski R
    HIV pre-exposure prophylaxis: the primary care implications of prescribing restrictionsBr J Gen Pract2017DOI: https://doi.org/10.3399/bjgp17X691541.
  2. 2.↵
    1. GBD 2017 HIV Collaborators
    Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017 and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017Lancet HIV2019612e831e859
    OpenUrlPubMed
  3. 3.↵
    1. HSE Health Protection Surveillance Centre
    Annual epidemiological report: HIV in Ireland, 20182019https://www.hpsc.ie/a-z/hivandaids/hivdataandreports/HIV_2018_final.pdf (accessed 9 Apr 2020).
  4. 4.↵
    1. Hudson-Sharp N,
    2. Metcalf H
    Inequality among lesbian, gay bisexual and transgender groups in the UK: a review of evidence2016https://www.gov.uk/government/publications/inequality-among-lgbt-groups-in-the-uk-a-review-of-evidence (accessed 9 Apr 2020).
  5. 5.↵
    1. Rendina HJ,
    2. Gamarel KE,
    3. Pachankis JE,
    4. et al.
    Extending the minority stress model to incorporate HIV-positive gay and bisexual men’s experiences: a longitudinal examination of mental health and sexual risk behaviorAnn Behav Med2017512147158
    OpenUrl
  6. 6.↵
    1. Sullivan PS,
    2. Carballo-Diéguez A,
    3. Coates T,
    4. et al.
    Successes and challenges of HIV prevention in men who have sex with menLancet20123809839388399
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Sewell J,
    2. Cambiano V,
    3. Speakman A,
    4. et al.
    Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: findings from the AURAH2 studyInt J Drug Policy2019685461
    OpenUrl
  8. 8.↵
    1. Barrett P,
    2. O’Donnell K,
    3. Fitzgerald M,
    4. et al.
    Drug use among men who have sex with men in Ireland: prevalence and associated factors from a national online surveyInt J Drug Policy201964512
    OpenUrl
  9. 9.↵
    1. Molina J-M,
    2. Capitant C,
    3. Spire B,
    4. et al.,
    5. ANRS IPERGAY Study Group
    On-demand preexposure prophylaxis in men at high risk for HIV-1 infectionN Engl J Med20153732322372246
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Health Information and Quality Authority
    Health technology assessment of a PrEP programme for populations at substantial risk of sexual acquisition of HIV2019https://www.hiqa.ie/sites/default/files/2019-06/PrEP-HTA.pdf (accessed 9 Apr 2020).
  11. 11.↵
    1. Cambiano V,
    2. Miners A,
    3. Dunn D,
    4. et al.
    Cost- effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluationLancet Infect Dis20181818594
    OpenUrl
  12. 12.↵
    1. Hayes R,
    2. Schmidt AJ,
    3. Pharris A,
    4. et al.
    Estimating the ‘PrEP gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019Euro Surveill20192441
  13. 13.↵
    1. Lochlainn LN,
    2. O’Donnell K,
    3. Hurley C,
    4. et al.
    HIV pre-exposure prophylaxis (PrEP) in Ireland: PrEP estimates for populations at risk of sexual acquisition of HIV in Ireland2017https://www.hpsc.ie/a-z/hivandaids/hivtreatmentandprep/Ireland%20PrEP%20report%20v1.0_2017.pdf (accessed 9 Apr 2020).
  14. 14.↵
    1. Brooks H,
    2. Llewellyn CD,
    3. Nadarzynski T,
    4. et al.
    Sexual orientation disclosure in health care: a systematic reviewBr J Gen Pract2018DOI: https://doi.org/10.3399/bjgp18X694841.
  15. 15.↵
    1. Marcus JL,
    2. Levine K,
    3. Grasso C,
    4. et al.
    HIV preexposure prophylaxis as a gateway to primary careAm J Public Health20181081014181420
    OpenUrl
  16. 16.↵
    1. Department of Health (ROI)
    Sláintecare action plan 20192019https://www.gov.ie/en/publication/109e2b-slaintecare-action-plan-2019 (accessed 9 Apr 2020).
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 70 (697)
British Journal of General Practice
Vol. 70, Issue 697
August 2020
  • Table of Contents
  • Index by author
Download PDF
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pre-exposure prophylaxis and primary care
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pre-exposure prophylaxis and primary care
Des Crowley, Walter Cullen, Patrick O’Donnell
British Journal of General Practice 2020; 70 (697): 409-410. DOI: 10.3399/bjgp20X712097

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pre-exposure prophylaxis and primary care
Des Crowley, Walter Cullen, Patrick O’Donnell
British Journal of General Practice 2020; 70 (697): 409-410. DOI: 10.3399/bjgp20X712097
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • INTRODUCTION
    • HEALTH DISPARITIES AND MINORITY STRESS
    • A COMPREHENSIVE APPROACH TO HIV PREVENTION
    • PRE-EXPOSURE PROPHYLAXIS IN IRELAND AND THE UK
    • ‘PrEP GAP’
    • SEXUAL ORIENTATION DISCLOSURE
    • CONCLUSION AND RECOMMENDATIONS
    • Notes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • What has postmodernism ever done for us?
  • Fractional exhaled nitric oxide (FeNO): the future of asthma care?
  • How can autistic adults be supported in primary care?
Show more Analysis

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

Tweets by @BJGPjournal

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242